Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Dubermatinib |
Trade Name | |
Synonyms | TP-0903 |
Drug Descriptions |
Dubermatinib (TP-0903) is a selective Axl inhibitor that inhibits tumor cell survival (PMID: 22247788, PMID: 32460059, PMID: 31992541). |
DrugClasses | AXL Inhibitor 30 |
CAS Registry Number | 1341200-45-0 |
NCIT ID | C127116 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Azacitidine + Dubermatinib | Azacitidine Dubermatinib | 0 | 1 |
Dubermatinib | Dubermatinib | 10 | 3 |
Dubermatinib + Gemcitabine | Dubermatinib Gemcitabine | 0 | 0 |
Dubermatinib + Gemcitabine + unspecified PD-1 antibody | Dubermatinib Gemcitabine unspecified PD-1 antibody | 0 | 0 |
Dubermatinib + Gilteritinib | Dubermatinib Gilteritinib | 1 | 0 |
Dubermatinib + Ibrutinib | Dubermatinib Ibrutinib | 0 | 1 |
Dubermatinib + Olaparib | Dubermatinib Olaparib | 0 | 0 |
Dubermatinib + Sorafenib | Dubermatinib Sorafenib | 1 | 0 |